Medical Devices

A new Premier Inc. designation gives BRIJ Medical vast market access for its hypoallergenic BRIJ-SEAL, signaling a shift in post-operative care standards.

Dr. Howard Bailey, a top cancer center leader, joins Cofactor Genomics. It's a strategic bet on RNA's power to finally predict immunotherapy success.

A Pennsylvania clinic's radical 19-day protocol, powered by advanced hyperbaric tech, is showing remarkable results for veterans with TBI and PTSD.

With a lens clinically shown to stop nearsightedness in 9 of 10 kids, HOYA isn't just launching a product; it's making a power play in a blurry market.

MIMEDX's $350M Sanara deal creates a surgical powerhouse, combining complementary portfolios to accelerate growth and challenge market leaders in regenerative medicine.

As Hamilton Beach sets its Q2 earnings call, the focus is less on kitchen gadgets and more on its strategic pivot into healthcare and commercial markets.

CorVascular's new DuplexABI, developed with Terason, merges two key vascular tests. Can this workflow innovation overcome complex reimbursement hurdles?

A $3.5M fundraiser is just the start. Northwell's Feinstein Institutes are turning donations into FDA-approved nerve implants that are changing medicine.

As RenovoRx preps its Q2 update, it's proving its mettle on two fronts: impressive sales of its RenovoCath device and a critical milestone in its pancreatic cancer trial.

A new class of disposable devices makes a common surgery four times faster and five times less bloody. So why is this Asia-led innovation invisible to US regulators?

A new study on umbilical cord allografts offers hope for chronic neck pain, but a closer look reveals the complex scientific and regulatory networks that will define its future.

Facing delisting and declining revenue, STRATA taps a commercial expert to turn reimbursement codes into a growth story. It's a high-stakes MedTech pivot.

BGLC aims to upend cancer monitoring in emerging markets with a low-cost liquid biopsy. But can a micro-cap execute on this billion-dollar vision?

A new partnership between B-Secur and CSEM combines ECG and PPG tech, promising to turn consumer wearables into powerful, clinically-validated heart monitors.

A landmark FDA approval allows Walter Reed to 3D-print cranial implants on-site, a strategic shift in military medicine powered by 3D Systems' expertise.

With $26M in new funding, Epitel is scaling its wireless, AI-powered EEG system, aiming to revolutionize seizure diagnosis and bridge a critical care gap.

A 57% stock plunge and a securities fraud lawsuit against Embecta Corp. reveal the high stakes of corporate guidance and the new era of accountability.

With labs facing staff shortages and rising demand, SCIEX's new software and hardware promise to speed up critical test results from sample to answer.

Thermo Fisher's latest innovations tackle medicine's toughest challenges, from cancer to preeclampsia, using automation and rapid data to redefine diagnostics.

New trial data shows an incision-free therapy preserves patient quality of life, challenging the long-held dominance of robotic surgery in prostate cancer.